Human BAFF Protein

<strong>Human BAFF Protein</strong>_x000D_ <strong>Catalog number:</strong> B2013688_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 20 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 17.0 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞ C_x000D_ <strong>Keywords:</strong> B-cell Activation Factor, TALL-1, THANK, BLyS_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Fan Y, Gao D, Zhang Z. Telitacicept, a novel humanized, recombinant TACI-Fc fusion protein, for the treatment of systemic lupus erythematosus Drugs Today (Barc). 2022 Jan;58(1):23-32._x000D_ 2: Shi F, Xue R, Zhou X, Shen P, Wang S, Yang Y. Telitacicept as a BLyS/APRIL dual inhibitor for autoimmune disease Immunopharmacol Immunotoxicol. 2021 Dec;43(6):666-673._x000D_ 3: Vincent FB, Saulep-Easton D, Figgett WA, Fairfax KA, Mackay F. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity Cytokine Growth Factor Rev. 2013 Jun;24(3):203-15._x000D_ 4: Samy E, Wax S, Huard B, Hess H, Schneider P. Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases Int Rev Immunol. 2017 Jan 2;36(1):3-19._x000D_ 5: Zhang Y, Tao M, Chen C, Zhao X, Feng Q, Chen G, Fu Y. BAFF Blockade Attenuates DSS-Induced Chronic Colitis via Inhibiting NLRP3 Inflammasome and NF-B Activation Front Immunol. 2022 Mar 7;13:783254._x000D_ 6: Qin H, Wei G, Sakamaki I, Dong Z, Cheng WA, Smith DL, Wen F, Sun H, Kim K, Cha S, Bover L, Neelapu SS, Kwak LW. Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo Clin Cancer Res. 2018 Mar 1;24(5):1114-1123._x000D_ 7: Eslami M, Meinl E, Eibel H, Willen L, Donz O, Distl O, Schneider H, Speiser DE, Tsiantoulas D, Yalkinoglu , Samy E, Schneider P. BAFF 60-mer, and Differential BAFF 60-mer Dissociating Activities in Human Serum, Cord Blood and Cerebrospinal Fluid Front Cell Dev Biol. 2020 Nov 6;8:577662._x000D_ 8: Wang X, Zhang Q, Luo S, Zhang H, Lu Q, Long H. Advances in therapeutic targets-related study on systemic lupus erythematosus Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Nov 28;46(11):1267-1275._x000D_ 9: Tong Y, Zhong S, Shan Z, Yao W, Tian H. A novel human anti-BAFF neutralizing monoclonal antibody derived from in vitro immunization Biomed Pharmacother. 2019 Nov;119:109430._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/23359128">10: Gao XP, Liu ZM, Jiao YL, Cui B, Zhu YT, Zhang J, Wang LC, Zhao YR. Diphtheria Toxin/Human B-Cell Activating Factor Fusion Protein Kills Human Acute Lymphoblastic Leukemia BALL-1 Cells: An Experimental Study Chin J Cancer Res. 2012 Sep;24(3):238-44. </a>_x000D_ _x000D_ <strong>Products Related to Human BAFF Protein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>